© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Hong Kong SAR

  • The Shanghai-Hong Kong Stock Connect is approaching its first birthday, with market participants eager to see the scheme expanded to reach its full potential with the inclusion of the Shenzhen-listed stocks as the first order of business and a potential expansion overseas to London. But from an infrastructure perspective, there remains a wide gap between China and most developed markets.
  • China International Capital Corp (CICC), which is looking to raise HK$6.29bn ($811.61m) in a Hong Kong IPO, has sent out a covered book message to investors ahead of its expected pricing on Friday.
  • Citi has hired a former Standard Chartered banker as its new chief economist for India.
  • Xinyi Solar has raised a smaller-than-expected HK$543.5m ($70.1m) from a top-up placement of shares, shrinking the deal by about 45% following its launch. Despite the transaction being slashed, sources are adamant the company found a good window to raise equity.
  • Golden Meditech has closed its HK$985.70m ($127.19m) rights issue with shareholders taking up just 69% of the transaction, forcing its underwriter to absorb the remaining shares.
  • Wenzhou Kangning Hospital Co started to test investor appetite for its IPO of around $100m on Monday, with bookbuilding expected to kick off in early November.
  • China International Capital Corp (CICC) is continuing the recent run of Hong Kong IPOs counting on heavy cornerstone support from state-owned enterprises. The investment bank opened books on Monday for a HK$6.29bn ($811.61m) listing, with about half the trade already covered by SOEs.
  • Standard Chartered has decided to exit its equity derivatives and convertible bonds businesses in yet another move by the bank to bolster its performance by withdrawing from non-core operations.
  • Wenzhou Kangning Hospital Co is set to pre-market its $100m Hong Kong IPO on October 26, with investor education slated to run for about two weeks before bookbuilding starts.
  • A shareholder in Hong Kong-listed Phoenix Healthcare Group has raised HK$894m ($115.35m) by selling some of his shares in the company via a block trade.
  • Bookrunners on a S$192m ($137.8m) loan for Citic Envirotech are sounding out a select group of banks to join the deal in syndication.
  • China Huarong Asset Management pulled off a HK$17.83bn ($2.30bn) IPO on October 22, pricing one of Hong Kong’s largest listings this year just a few cents off the bottom of the initial range. But the price tag has sparked debate among bankers, with some saying the issuer was pushing its luck.